The global CAR-T Cell Therapy market size is expected to reach USD 8.92 billion by 2026 growing at a CAGR of 34.5% from 2020 to 2026 according to a new study published by Report Ocean. Request To ...
Women – especially teen girls and young women living in sub-Saharan Africa – are disproportionately impacted by <a ...
Grace Place: 2024 Haus of Gingerbread Haus of Gingerbread, benefitting the youth of Grace Place, is even bigger and better ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
In Uganda, women and girls are more affected by HIV. Out of 1.4 million people living with the disease, 860 000 are women and ...
Long-awaited results released Tuesday showed adding tiragolumab to Roche's immunotherapy Tecentriq did not extend survival in ...
17h
As the U.S. prepares to welcome a new presidential administration, leaders from business, public health, and community ...
Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.
Spanish HIV focused immunotherapies company AELIX Therapeutics, a spin-off of IrisCaixa, has announced the acquisition of its ...
The company’s shares closed yesterday at $8.91. Don't Miss our Black Friday Offers: Van Buren covers the Healthcare sector, focusing on stocks such as Regeneron, Oruka Therapeutics, and Gilead ...
DelveInsight's "Crohn’s Disease Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback